A retrospective review of 11 cases of villoglandular papillary adenocarcinoma of the uterine cervix and a review of the literature

Zhao,Liping; Xu,Tianmin; Cui,Manhua; Fu,Zeming

doi:10.3892/ol.2016.4172

A retrospective review of 11 cases of villoglandular papillary adenocarcinoma of the uterine cervix and a review of the literature

Authors:
- Liping Zhao
- Tianmin Xu
- Manhua Cui
- Zeming Fu
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
Published online on: February 1, 2016 https://doi.org/10.3892/ol.2016.4172
Pages: 2164-2168

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Villoglandular papillary adenocarcinoma (VGPA) of the uterine cervix is a rare subtype of cervical adenocarcinoma (AC) that accounts for 3.7‑4.8% of cervical AC. Compared with ordinary adenocarcinoma, VGPA is associated with a lower incidence, younger age and better prognosis. Treatment with fertility‑preserving surgery is also possible. The present study analyzed cases treated in The Second Hospital of Jilin University (Changchun, Jilin, China) between January 2010 and December 2014. A total of 11 cases were selected; of these, 7 cases were pathologically confirmed. The remaining 4 cases were diagnosed as VGPA upon the pathological examination of the biopsy, but confirmed as another type of adenocarcinoma upon analysis of the surgical pathology. The median age of the patients whose pathology was confirmed post‑operatively was 36 years, and all cases were positive for human papillomavirus (HPV). As all 7 patients had no requirement for further fertility, a radical hysterectomy was performed, with or without adjuvant therapy. The follow‑up time ranged from 7‑57 months, with a mean time of 29 months. There was no evidence of recurrence in any of the patients. All the patients remain alive to date. The results of the present study indicated that HPV infection is likely to be the cause of VGPA, and the prognosis of VGPA tends to be better compared with other types of adenocarcinoma. However, the number of studies that have reported cases of VGPA remains small, and all are retrospective analyses with short follow-up times. Therefore, physicians selecting treatment options for patients with VGPA should exercise caution.

View Figures

View References

1	Young RH and Scully RE: Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer. 63:1773–1779. 1989. View Article : Google Scholar : PubMed/NCBI
2	Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG and Wilkinson EJ: Uterine cervix. In: Histological Typing of Female Genital Tract Tumors. World Health Organization International Histological Classification of Tumors (2nd). (New York, NY). Springer-Verlag. 1994.
3	Jones MW, Kounelis S, Papadaki H, Bakker A, Swalsky PA, Woods J and Finkelstein SD: Well-differentiated villoglandular adenocarcinoma of the uterine cervix: Oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol. 19:110–117. 2000. View Article : Google Scholar : PubMed/NCBI
4	An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, Suh KS, Seo EJ, Sung SH, Sohn JH, et al: Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: A population-based study. Mod Pathol. 18:528–534. 2005. View Article : Google Scholar : PubMed/NCBI
5	Khunamornpong S, Siriaunkgul S and Suprasert P: Well-differentiated villoglandular adenocarcinoma of the uterine cervix Cytomorphologic observation of five cases. Diagn Cytopathol. 26:10–14. 2002. View Article : Google Scholar : PubMed/NCBI
6	Korach J, Machtinger R, Perri T, Vicus D, Segal J, Fridman E and Ben-Baruch G: Villoglandular papillary adenocarcinoma of the uterine cervix: A diagnostic challenge. Acta Obstet Gynecol Scand. 88:355–358. 2009. View Article : Google Scholar : PubMed/NCBI
7	Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
8	Heatley MK: Villoglandular adenocarcinoma of the uterine cervix-a systematic review of the literature. Histopathology. 51:268–269. 2007. View Article : Google Scholar : PubMed/NCBI
9	Nagai N, Hirata E, Kusuda T, Mukai K, Arihiro K and Ohama K: Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: A case report. Int J Gynecol Cancer. 15:1187–1190. 2005. View Article : Google Scholar : PubMed/NCBI
10	Macdonald RD, Kirwan J, Hayat K, Herrington CS and Shawki H: Villoglandular adenocarcinoma of the cervix: Clarity is needed on the histological definition for this difficult diagnosis. Gynecol Oncol. 100:192–194. 2006. View Article : Google Scholar : PubMed/NCBI
11	Jones MW, Silverberg SG and Kurman RJ: Well-differentiated villoglandular adenocarcinoma of the uterine cervix: A clinicopathological study of 24 cases. Int J Gynecol Pathol. 12:1–7. 1993. View Article : Google Scholar : PubMed/NCBI
12	Hoffman JS, Bazzurini L, Laird L, Murphy JC, Magriples U and Lewis J: Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: Report of a case and analysis of the literature. Gynecol Oncol. 81:310–313. 2001. View Article : Google Scholar : PubMed/NCBI
13	Dede M, Deveci G, Deveci MS, Yenen MC, Goktolga U, Dilek S and Gunhan O: Villoglandular papillary adenocarcinoma of the uterine cervix in a pregnant woman: A case report and review of literature. Tohoku J Exp Med. 202:305–310. 2004. View Article : Google Scholar : PubMed/NCBI
14	Falcon O, Garcia R, Lubrano A, Morín JC and Andujar M: Successful term delivery following conservative management for villoglandular papillary adenocarcinoma of the uterine cervix: A case report. Gynecol Oncol. 101:168–171. 2006. View Article : Google Scholar : PubMed/NCBI
15	Yamazawa K, Matsui H, Seki K, Mitsuhashi A, Kawamata Y, Shirasawa H and Sekiya S: Human papillomavirus-positive well-differentiated villoglandular adenocarcinoma of the uterine cervix: A case report and review of the literature. Gynecol Oncol. 77:473–477. 2000. View Article : Google Scholar : PubMed/NCBI
16	Hurteau JA, Rodriguez GC, Kay HH, Bentley RC and Clarke-Pearson D: Villoglandular adenocarcinoma of the cervix: A case report. Obstet Gynecol. 85:906–908. 1995. View Article : Google Scholar : PubMed/NCBI
17	Lavie O, Segev Y, Peer G, Gutterman E, Sagie S and Auslnader R: Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: A case report and a review of the literature. Eur J Surg Oncol. 34:606–608. 2008. View Article : Google Scholar : PubMed/NCBI
18	Takai N, Hayashita C, Nakamura S, Narahara H and Matsumoto H: A case of villoglandular papillary adenocarcinoma of the uterine cervix diagnosed during early pregnancy followed by successful term delivery. Case Rep Med. 2010:3145472010.PubMed/NCBI
19	Kaku T, Kamura T, Shigematsu T, Sakai K, Nakanami N, Uehira K, Amada S, Kobayashi H, Saito T and Nakano H: Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern. Gynecol Oncol. 64:147–152. 1997. View Article : Google Scholar : PubMed/NCBI
20	Lataifeh IM, Al-Hussaini M, Uzan C, Jaradat I, Duvillard P and Morice P: Villoglandular papillary adenocarcinoma of the cervix: A series of 28 cases including two with lymph node metastasis. Int J Gynecol Cancer. 23:900–905. 2013. View Article : Google Scholar : PubMed/NCBI
21	Kim HJ, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS and Lee JW: Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix. Int J Gynecol Cancer. 24:1299–1305. 2014. View Article : Google Scholar : PubMed/NCBI